leisure time -WSS

leisure time

author：focus 2025-09-29 10:40:23 - browse：59949

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Having children helps parents live longer, especially after age 80

WSS

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Here’s what’s in the FDA plan to include pregnant women in clinical trials

After Sarepta trial failure, Duchenne families brace for more debate

Medicare must police algorithms in Medicare Advantage, Dems say

All of Us, NIH's precision medicine initiative, gets a big boost

explore

leisure time

entertainment

Sports medicine is finally prioritizing gender equality

Ebola vaccine can save some who are already sick, per new study

Peter Hotez and the public health issue of online harassment

Why Eli Lilly’s earnings didn’t quite live up to the hype

The high cost of giving birth even with insurance

Too many hospitalized Covid

How one medical school became remarkably diverse

Prime Medicine says its gene editing passes test in monkeys

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Life sciences investors close nearly $6 billion in new funds

entertainment

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Key Senate panel to consider PBM, drug pricing reform package

Explaining an after

What is microchimerism and how does it affect maternal health?

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Why Eli Lilly’s earnings didn’t quite live up to the hype

entertainment

knowledge

Wikipedia

focus